EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Camzyos Adolescent Trial Success Might Change The Case For Investing In Bristol-Myers Squibb (BMY)
Is Bristol Myers Squibb (BMY) Price Near US$60 Supported By Cash Flow And Earnings Models
Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry
Ariel Global Fund Re-Added Bristol-Myers Squibb Company (BMY) on Pipeline Strength and Attractive Valuation
Ovarian Cancer Drugs Market Outlook Report 2026-2030 Featuring Strategic Analysis of AstraZeneca, Roche, Bristol-Myers Squibb Company, Clovis Oncology, Pfizer and Other Key Players
Retirement Systems of Alabama Boosts Position in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Purchased by Retirement Systems of Alabama - Daily Political
MOAT ETF Is Down 7% in 2026. Here Is the Macro Signal That Changes Everything
Advanced Melanoma Markets and Companies 2026-2030: Cumulative Revenue to Grow by $1.87 Billion
Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline
Paranasal Sinus Cancer Markets and Competition Outlook 2026-2030 - Precision Oncology, Minimally Invasive Surgeries, and Expanded Cancer Care Models Drive Revenue Growth
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Markets and Competition Outlook 2026-2030: Personalized Medicine Drives Revenue Growth, Reaching $4.61 Billion by 2030
Non-Small Cell Lung Cancer (NSCLC) Global Market Trends and Regional Growth Insights 2026-2030: Rapid Adoption of Targeted Therapies and Immunotherapy Fuels Market Expansion, Reaching $70.8 Billion by 2030
Exchange Traded Concepts LLC Decreases Stock Holdings in Bristol Myers Squibb Company $BMY
1 Surging Stock with Impressive Fundamentals and 2 That Underwhelm
Northwest Wealth Management LLC Makes New $689,000 Investment in Bristol Myers Squibb Company $BMY - Stock Observer
Bristol-Myers Squibb Gets FDA Approval for Hodgkin's Lymphoma Treatment
15 Large-cap Stocks with Highest Dividends
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial
Is Bristol-Myers Squibb Company (BMY) A Good Stock To Buy Now?
Cobenfy Phase 4 Data May Reframe Bristol Myers Squibb Valuation Story
Trial met its primary endpoint, demonstrating clinically mea
Precision Medicine Breakthrough: Mavacamten Markedly Reduces Heart Obstruction in Teens with Hypertrophic Cardiomyopathy
Bristol Myers Squibb Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) | Morningstar
Bristol Myers announces data from Phase 4 trial of Cobenfy | Markets Insider
Bristol-Myers Squibb Company (NYSE:BMY) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
A Look At Bristol Myers Squibb (BMY) Valuation As Growth Portfolio Outperforms Recent GAAP Loss
Bristol-Myers Squibb (BMY) Faces Mixed Analyst Sentiment Despite Strong Momentum in Healthcare Industry
Wedge Capital Management L L P NC Decreases Stake in Bristol Myers Squibb Company $BMY
Top Pharmaceutical Stocks To Watch Today - March 25th - Markets Daily
PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026
Nepsis Inc. Acquires 90,852 Shares of Bristol Myers Squibb Company $BMY
High treatment completion and no discontinuations due to lac
Top 10 Stocks to Invest in For Financial Stability
Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy™ (xanomeline and trospium chloride) | Morningstar
Bristol Myers Squibb Company $BMY Shares Sold by Wedge Capital Management L L P NC - Stock Observer
Kaufman Rossin Wealth LLC Invests $629,000 in Bristol Myers Squibb Company $BMY - Stock Observer
ET Pharma: Pharma News | Latest Pharma Sector Information and Updates
Jim Cramer on Bristol-Myers Squibb: "The Stock's Recent Pullbacks Have Represented Terrific Buying Opportunities"
Anti-Cancer MAbS Market Report 2026-2030 Featuring Strategic Analysis of Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, Roche, GlaxoSmithKline and Other Key Players
Oncology Precision Medicine Market Trends and Investment Opportunities 2026-2030 - Advancements in CAR-T and Gene Therapies Propel Precision Oncology Growth
A Look At Bristol Myers Squibb (BMY) Valuation As Shares Show Mixed Recent Returns
A New Era in Schizophrenia Care: National Council for Menta
Global X Japan Co. Ltd. Raises Stock Position in Bristol Myers Squibb Company $BMY - Stock Observer
BMS-986482 induces pan-IKZF degradation and robust tumor growth inhibition | BioWorld
Metastatic Triple-Negative Breast Cancer Market: Strong Growth Potential Across APAC Through 2036, Driven by Innovation and Rising Disease Burden | DelveInsight
Stocks making big moves yesterday: Robinhood, Payoneer, Micron, Limbach, and Bristol-Myers Squibb
Expanded Opdivo Use and New Camzyos Data Could Be A Game Changer For Bristol Myers Squibb (BMY)
Bristol Myers Squibb Company $BMY Position Raised by Czech National Bank
Erste Group Bank Has Positive Outlook of BMY FY2026 Earnings - Daily Political
Moody National Bank Trust Division Has $1.32 Million Stake in Bristol Myers Squibb Company $BMY - Daily Political
Why Bristol-Myers Squibb (BMY) Stock Is Up Today
SCHD Annual Reconstitution: Here's What This Dividend ETF Looks Like Now - AOL
Top Pharmaceutical Stocks To Watch Today - March 25th - Daily Political
Bristol Myers Squibb Leans On AI ALS Pact As Valuation Question Persists
Pensionfund Sabic Takes $1.85 Million Position in Bristol Myers Squibb Company $BMY - Daily Political
First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial
Procyon Advisors LLC Sells 20,349 Shares of Bristol Myers Squibb Company $BMY - Markets Daily
Colgate-Palmolive Board And Asia Leadership Shifts Spark Value Questions
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill.
E. Ohman J or Asset Management AB Buys 46,000 Shares of Bristol Myers Squibb Company $BMY
Insitro and Bristol Myers Squibb expand ALS collaboration | BioWorld
Enhanced dynamic risk stratification of smoldering multiple myeloma
Wealth Enhancement Advisory Services LLC Purchases 318,898 Shares of Bristol Myers Squibb Company $BMY
Replimune's Oncolytic Viral Therapy For Melanoma Faces Second Shot At FDA Approval
Opdivo's New cHL Approvals Reframe Bristol-Myers Squibb Growth Story
NorthCrest Asset Manangement LLC Has $24.56 Million Stock Position in Bristol Myers Squibb Company $BMY - Daily Political
A Look At Bristol Myers Squibb (BMY) Valuation As Recent Results Shape Growth And Cost Outlook
20,156 Shares in Bristol Myers Squibb Company $BMY Purchased by MFG Wealth Management Inc. - Stock Observer
Bristol Myers Squibb Company $BMY Shares Acquired by TruWealth Advisors LLC - Daily Political
Bristol Myers Squibb Gets Expanded Opdivo Approval in U.S., Europe | Morningstar
In the U.S., FDA approval establishes Opdivo in combination
Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab) | Morningstar
Union Bancaire Privee UBP SA Boosts Stake in Bristol Myers Squibb Company $BMY
Miller Global Investments LLC Invests $1.11 Million in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Purchased by Mirabella Financial Services LLP
Union Bancaire Privee UBP SA Boosts Position in Bristol Myers Squibb Company $BMY - Daily Political
20,650 Shares in Bristol Myers Squibb Company $BMY Bought by Miller Global Investments LLC - Daily Political
Bristol Myers Squibb Kidney Cancer Trial Tests Valuation And Pipeline Depth
Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium
International testing and refinement of AI algorithms predicting acute leukemia subtypes from routine laboratory data
These 3 Stocks Trigger Bearish Signals but 2 Offer Hidden Opportunity
Bristol Myers Squibb Tests New Protein Degradation Cancer Drug In Humans
12,955 Shares in Bristol Myers Squibb Company $BMY Purchased by Investment Research Partners LLC - Daily Political
How Mezigdomide Trial Progress And Sotyktu Expansion At Bristol Myers Squibb (BMY) Has Changed Its Investment Story
WBI Investments LLC Has $2.70 Million Stock Holdings in Bristol Myers Squibb Company $BMY
20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style
Danske Bank A S Makes New $71.59 Million Investment in Bristol Myers Squibb Company $BMY
BristolMyers News
Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact
Meta Platforms: Navigating Legal Headwinds and AI Opportunities for Investors
US Stocks Poised for Potential Rebound Amidst Easing Geopolitical Tensions and Shifting Investor Positioning
UAE as Global Gold Powerhouse: Analyzing the 2026 Resilience of Dubai’s Gold Trading Ecosystem
Investing in US Stocks from South Africa: Step-by-Step Guide for ZA Investors
How to Invest in Stocks for Beginners (Europe): Opportunities, Risks and Smart Strategies in 2026
Forex Market Today: BRICS+ Currency Dynamics, USD/AED Stability, Key Currency Trading Opportunities
Latest news
Show moreUkraine Forges New Alliances in the Middle East, Leveraging Defense Expertise
Fed Policy Pivot: Inflation Risks Hint at Potential Rate Hikes, Shifting Market Expectations
TotalEnergies Dominates Middle East Oil Market in March, Securing Record Profits
Navigating Economic Crosscurrents: Market Outlook Amidst Geopolitical Turmoil
Ukraine Hints at Reduced Strikes on Russian Energy Amid Partner Pressure, Secures Middle East Support
